Skip to main content
Fig. 4 | Stem Cell Research & Therapy

Fig. 4

From: MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model

Fig. 4

Exo MSC-NTF repress several LPS-induced immune effects in the bronchoalveolar lavage fluid (BALF) of LPS-treated mice. Quantification of the immune response in the BALF of treated mice. Measurements of a IFN-γ, b IL-6, c RANTES, and d TNF-α using ProcartaPlex platform. A measure of coagulation by e tissue factor and f thrombin–antithrombin complex (TAT) using ELISA. Mean ± SEM, n = 9–10 (ProcartaPlex) or 9–13 (ELISA). ap < 0.05 vs. no LPS control, bp < 0.05 vs. LPS + PlasmaLyte, b#p = 0.058 vs. LPS + PlasmaLyte. One-way ANOVA followed by Tukey’s post hoc

Back to article page
\